Early Detection of Relapses in Stage IV Colorectal Cancer Patients
NCT04232891 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 141
Last updated 2020-01-18
Summary
This study is a prospective, multicenter, observational study on metastatic, operable colorectal cancer to evaluate the proof of concept of the cfDNA analysis for the early detection of recurrences
Conditions
Interventions
- DIAGNOSTIC_TEST
-
liquid biopsy
detection of tumor DNA alteration in cf-DNA
Sponsors & Collaborators
-
Fondazione del Piemonte per l'Oncologia
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-11-18
- Primary Completion
- 2021-06-30
- Completion
- 2023-06-30
Countries
- Italy
Study Locations
More Related Trials
-
A Comparative Study Between Early Onset Colorectal Cancer and Late Onset Colorectal Cancer Patients
NCT06326879 ·Status: RECRUITING
-
Presence of Circulating Tumor DNA in Colorectal Cancer
NCT01198743 ·Status: COMPLETED
-
Diagnostic and Prognosis Value of Circulating DNA for CRC Patients' Surveillance After Curative Treatment
NCT02813928 ·Status: COMPLETED ·Phase: NA
-
An Evaluation of a Multi-target Stool DNA (Mt-sDNA) Test, Cologuard, for CRC Screening in Individuals Aged 45-49 and at Average Risk for Development of Colorectal Cancer: Act Now
NCT03728348 ·Status: COMPLETED
-
Predictive Value of Drug Sensitivity Testing Tumorspheres From Patients With Metastatic Colorectal Cancer
NCT03251612 ·Status: COMPLETED ·Phase: PHASE2
-
Liquid Biopsy in Early Colorectal Lesions
NCT07319104 ·Status: NOT_YET_RECRUITING
-
Application of FIT-DNA Detection in Following Colorectal Cancer Resection-Implications for Surveillance
NCT05528783 ·Status: RECRUITING
-
Predicting Local and Distant Recurrence in T1 Colorectal Cancer
NCT06314971 ·Status: COMPLETED
-
Blood and Stool Sample Collection in Subjects With a Diagnosis of Colorectal Cancer or Colorectal Lesion: Act Fast
NCT03789162 ·Status: COMPLETED
-
Circulating Tumor DNA in Patients Summoned for Colonoscopy; - a Liquid Biopsy for Detection, Characterization, Individualized Treatment and Follow-up of Colorectal Cancer
NCT06307938 ·Status: RECRUITING
-
Exploratory Study of a Novel Based rbcDNA Liquid Biopsy Technique for Colorectal Cancer Early Detection
NCT05875584 ·Status: COMPLETED
-
the Role of ctDNA in Predicting the Recurrence Risk of Colorectal Cancer
NCT05131243 ·Status: UNKNOWN ·Phase: NA
-
The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors
NCT04624555 ·Status: RECRUITING
-
The Detection of Circulating Tumor Cells (CTCs) in Patients With Colorectal Cancer Undergoing Cryosurgery Combined With DC-CIK Treatment
NCT02450422 ·Status: COMPLETED
-
Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer
NCT06889883 ·Status: RECRUITING
-
A Novel Patent Platform of Detection of Circulating Tumor Cells to Early Detect Colorectal Cancer Recurrence
NCT02005913 ·Status: UNKNOWN
-
Prognostic Value of Circulating Tumoral Free DNA Versus Circulating Tumoral Cells in Patients With Colorectal Cancer Stage II-III
NCT02556281 ·Status: COMPLETED ·Phase: NA
-
Clinical Application of an Automated Liquid Biopsy Platform for Early Detection of Colorectal Cancer
NCT03476122 ·Status: UNKNOWN
-
Colorectal Cancer Detection by Means of Optical Fluoroscopy
NCT01286064 ·Status: UNKNOWN ·Phase: NA
-
RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based
NCT06614647 ·Status: RECRUITING ·Phase: NA
-
Prospective Collection of Samples to Enable the Development of Natera Screening Assay for Early Cancer Detection
NCT06620627 ·Status: RECRUITING
-
Metabolomics-Based Detection of Colorectal Cancer
NCT00507598 ·Status: COMPLETED
-
A Clinical Study on Endoscopic and Histopathological Outcomes of Screening and Surveillance Colonoscopies
NCT05869838 ·Status: COMPLETED
-
CRC Detection Reliable Assessment With Blood
NCT05551052 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of a Model for the Early Diagnosis of Colorectal Cancer by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA to the Community Colorectal Cancer Screening Program
NCT05638243 ·Status: UNKNOWN